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Abstract
Background: Recent studies have emphasized causative links between microRNAs (miRNAs) deregulation and tumor
development. In hepatocellular carcinoma (HCC), more and more miRNAs were identified as diagnostic and prognostic
cancer biomarkers, as well as additional therapeutic tools. This study aimed to investigate the functional significance and
regulatory mechanism of the miR-199a2/214 cluster in HCC progression.
Methods and Findings: In this study, we showed that miR-214, as well as miR-199a-3p and miR-199a-5p levels were
significantly reduced in the majority of examined 23 HCC tissues and HepG2 and SMMC-7721 cell lines, compared with their
nontumor counterparts. To further explore the role of miR-214 in hepatocarcinogenesis, we disclosed that the ER stress-
induced pro-survival factor XBP-1 is a target of miR-214 by using western blot assay and luciferase reporter assay. Re-
expression of miR-214 in HCC cell lines (HepG2 and SMMC-7721) inhibited proliferation and induced apoptosis.
Furthermore, ectopic expression of miR-214 dramatically suppressed the ability of HCC cells to form colonies in vitro and to
develop tumors in a subcutaneous xenotransplantation model of the BALB/c athymic nude mice. Moreover, reintroduction
of XBP-1s attenuated miR-214-mediated suppression of HCC cells proliferation, colony and tumor formation. To further
understand the mechanism of the miR-199a/214 cluster down-expression in HCC, we found that thapsigargin (TG) and
tunicamycin (TM) or hypoxia-induced unfolded protein response (UPR) suppresses the expression of the miR-199a/214
cluster in HCC cells. By promoter analysis of the miR-199a2/214 gene, we conjectured NFkB as a potential negative
regulator. We further found that UPR and LPS-induced NFkB activation suppressed miR-199a2/214 transcription, and this
suppression was reversed by NFkB inhibition in HCC cells.
Conclusions: Our study suggest that modulation of miR-214 levels may provide a new therapeutic approach for cancer
treatment and revealed that UPR may offer a new explanation for why the miR-199a/214 cluster were down-regulated in the
progression in HCC.
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Introduction
MiRNAs are a new class of endogenous, non-coding RNAs 19–
25 nucleotides long that mediate the repression of target
transcripts by binding to complementary seed sequences at the
39 untranslated regions (UTRs) of target mRNAs [1]. Since initial
observation, more than 1400 human miRNAs have been
registered in miRBase (v.17.0). Previous studies suggested
dysexpression of miRNAs has been observed in various types of
cancers and is also associated with the clinical outcome of cancer
patients [2]. Furthermore, the abilities of miRNAs to achieve
simultaneous fine tuning of numerous different target genes makes
them fundamental regulators of cellular signaling and implicates
them in tumor progression [3,4]. But their specific roles and
functions in the major cancers and the malignant progression of
cancer have yet to be fully elucidated.
Hepatocellular carcinoma (HCC) is one of the most common
cancers worldwide and among the leading causes of cancer-related
deathinAsia,especiallyinChina[5].SeveralmiRNAs,suchasmiR-
101 [6], miR-122 [7,8,9] miR-373 [10], miR-221/222 [11,12,13],
miR-195 [14], miR-30d [15], miR-125b [16], miR-18a [17], miR-
139 [18], miR-223 [19] and miR-29 [20], have already been
reported to regulate HCC tumor progression and metastasis by
regulatingkeygenes suchas Mcl-1,ADAM17,YAP,DDIT4, Cyclin
D1, CDK6, E2F3, Galphai2, LIN28B, estrogen receptor-a, Rho-
kinase 2,Stathmin1 and Bcl-2 and soon.However,the existing data
cannot fully explain the complexity of HCC.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31518Recently, miR-199a-3p/5p was verified to be decreased in
HCC tissues, and its decrement significantly correlates with the
survival of HCC patients, outlining a potential marker for
predicting the prognosis of HCC patients [5,21,22]. It is well
known that there are two genes that potentially encode pri-miR-
199a, the primary precursor of hsa-mir-199a. The first gene is
MIR199a1 on chromosome 19 (NCBI GeneID 406976) and the
second is MIR199a2 on chromosome 1 (NCBI GeneID 406977)
[23]. Interestingly, at the 39-end of the pri-miR-199a2 transcript,
there is the precursor sequence for another miRNA pair hsa-mir-
214 and hsa-mir-214* [24]. miR-199a2 and miR-214 have been
reported to be produced from a single intron-less transcript of
Dynamin 3 opposite (Dnm3os) that is embedded in the opposite
strand within an intron of Dynamin in mouse and human [23,24].
Furthermore, the miPPR-199a2 region is shown here to be the
authentic miR-199a2 promoter that produces the primary
transcript harboring the miR-199a-3p, miR-199a-5p and miR-
214 sequences as a cluster [25]. More and more studies
documented that miR-214 is involved in human ovarian cancer,
cervical cancer and melanoma tumour progression [26,27,28,29].
However, the current knowledge about miR-214 expression and
function in HCC is still rather unclear. In addition, the
mechanisms underlying miR-199a2/214 deregulation in HCC is
not yet clear.
In the present study, we showed that miR-199a-3p, miR-199a-
5p and miR-214 expression was significantly reduced in HCC
tissues. XBP-1 was shown to be a direct target of miR-214 by
interaction with the 39-UTR. Furthermore, the suppressive effect
of miR-214 in HCC tumor formation and growth was studied in
vitro and in vivo, and reintroduction of XBP-1s attenuated miR-
214-mediated suppression. We further identified that NFkB
activated by unfolded protein response (UPR) suppresses miR-
199a2/214 transcription, and demonstrated that activation of
UPR and endoplasmic reticulum (ER) stress represents an
important mechanism responsible for miR-214 and miR-199a-
3p/5p down-regulation in HCC development.
Results
miR-199a/214 is downregulated in HCC cell lines and
tissues
To study the role of the miR-199a/214 cluster in the HCC,
levels of miR-214 and miR-199a-3p/5p were determined in 23
pairs of HCC and adjacent benign tissues using real-time PCR.
Results showed that these miRNAs were all significantly down-
regulated and miR-199a-3p.miR-199a-5p.miR-214 compared
with adjacent nontumorous liver tissues. Decreased miR-214
expression was observed in 65% of HCC (15 of 23 cases), and
consistent down-regulation of both miR-199a-3p and miR-199a-
5p also were detected in as much as 73% of HCC (17 of 23 cases)
(Figure 1A and B). In parallel, in HCC cell lines HepG2 and
SMMC-7721, miR-199a-3p/5p and miR-214 expression was
markedly decreased compared with that in human normal liver
(Figure 1C).
miR-214 directly targets XBP-1 by interaction with the 39-
UTR
Identification of miRNA-regulated gene targets is a necessary
step to understand miRNA functions. Although miR-199a-3p and
Figure 1. miR-199a/214 expression in HCC samples and cell lines. (A) Box plot graphic displays of 23 HCC and matched adjacent benign
tissues grouped according to miR-199a-3p and miR-199a-5p expression. (B) Box plot graphic displays of 23 HCC and matched adjacent benign tissues
grouped according to miR-214 expression. (C) miR-199a/b-3p and miR-214 expression in human normal liver, HepG2, and SMMC-7721 HCC cell lines
was detected using real-time qRT-PCR. Columns, mean of three independent experiments; bars, SD; * P,0.05 vs control.
doi:10.1371/journal.pone.0031518.g001
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genesis [5,21,22], the role of miR-214 in HCC tumorigenesis has
not been elucidated. Therefore, we next searched for the target
genes of miR-214 in HCC. Putative miR-214 targets were
predicted using target prediction programs, miRBase and
TargetScan. We found that sequence alignment of hsa-miR-214
with 39-UTR of the human XBP-1 gene identified a miR-214
binding site (Figure 2A). To confirm that XBP-1 is a putative
target of miR-214, we constructed two luciferase reporter vectors
with wild-type XBP-1 39UTR and mutated XBP-1 39UTR (the
complementary sequence in the seed region of miR-214 binding
site was mutated). When co-transfected with miR-214 mimics into
HepG2 cells, the relative luciferase activity of a XBP-1 39UTR
luciferase reporter was significantly suppressed by ,50% com-
pared with the transfection of negative control. In contrast, no
change in relative luciferase activity was observed in cells
transfected with the mutant reporter or empty vector (Figure 2B).
These results suggest that miR-214 targets XBP-1 by directly
binding the 39 UTR of XBP-1.
We further found that transient transfection of HepG2 and
SMMC-7721 cells with miR-214 efficiently reduced XBP-1
protein levels detected by western blotting analysis (Figure 2C),
which was independent of ATF6 and IRE1 signaling (Figure S1).
Similar results were attained in human epithelial cervical cancer
Hela cells (Figure S2). These data suggest that miR-214 directly
recognizes the 39UTR of XBP-1 mRNA and inhibits XBP-1
translation.
Moreover, western blot analysis showed that XBP-1 protein
level was increased in miR-214-downregulated human HCC
tissues compared with adjacent nontumorous liver tissues (Figure
S3). Our analysis revealed that XBP-1 was a potential target of
miR-214.
miR-214 regulates HCC cell proliferation and apoptosis
Previous studies have implicated XBP-1 as an essential survival
factor for ER stress and tumor growth [30], thus we chose whether
miR-214 exert an opposite effect in HCC for further investigation.
To determine the impact of the miR-214 on HCC cell
proliferation, HepG2 and SMMC-7721 cells, were respectively
transfected with miR-214 mimics or miR-control and analyzed for
cell growth. The CCK-8 proliferation assay showed that cell
growth was decreased in miR-214 mimics-transfected HCC cells
compared with miR-control -transfected cells or untreated cells
(Figure 3A). Similar results were observed by Br-dU incorporation
assay in HepG2 and SMMC-7721 cells (Figure 3B). The results of
the in vitro assays indicated that exogenous miR-214 significantly
inhibited the proliferation of hepatoma cell lines.
Further, we tested whether upregulated miR-214 induces HCC
cell apoptosis and cell death, by determining the number of early
and late apoptotic HepG2 cells following treatments with miR-214
mimics by flow cytometric analysis. As expected, few Annexin V-
positive cells were detected in the miR-control-treated or
untreated cells, whereas miR-214 restoration increased the
percentage of apoptotic cells (,20% in HepG2) as judged by
Figure 2. miR-214 negatively regulates XBP-1 through binding to 39-UTR of the XBP-1. (A) Sequence alignment of human miR-214 with
39-UTR of XBP-1. The seed sequence of miR-214 matches 39-UTR of XBP-1 for creating the XBP-1 39-UTR or mutant luciferase reporter construct. (B)
miR-214 inhibits XBP-1 39-UTR reporter but not mutant reporter or empty reporter activity. HepG2 cells were transiently transfected with indicated
plasmids with miR-control, miR-214 mimics. Following 36 h of incubation, cells were subjected to luciferase assay. Columns, mean of three
independent experiments; bars, SD. * P,0.05 vs miR-con. (C) miR-214 reduces XBP-1 expression in HepG2 (left) and SMMC-7721(right) cells analyzed
by western blotting.
doi:10.1371/journal.pone.0031518.g002
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also detected in SMMC-7721 cells treated with cholesterol-
conjugated 29-O-methyl-modified miR-214 mimics (agomir-214)
(Figure 3D). These results indicate a growth-inhibitory role of
miR-214 in HCC.
miR-214 regulates HCC tumor formation and growth in
vitro and in vivo
The above findings prompted us to explore the biological
significance of miR-214 in HCC tumorigenesis in vivo. As an
initial step, the capacity of colony formation was evaluated on
SMMC-7721 cells transfected with agomir-214 and agomir
negative control (agomir-NC). Results showed that agomir-214-
treated cells displayed much fewer and smaller colonies compared
with agomir-NC treated cells (Figure 4A), which were consistent
with the cell proliferation assay. Further, agomir-NC- and agomir-
214-treated SMMC-7721 cells were injected s.c. into either
posterior flank of the same nude mice, respectively. After 4 weeks,
the size of the tumor nodules was examined. We found that the
tumor sizes and tumor weight at the end of observation were
significantly decreased in the agomir-214 treatment group
compared with that in the agomir-NC treatment group
(Figure 4B). Similar results were also found in HepG2 cell
xenografts trandfected with miR-214 mimics in vivo (Figure S4
and S5).These results suggest that miR-214 may function as a
putative tumor suppressor in HCC cells.
To further verify a potent role for the miR-214/XBP-1 pathway
in mediating tumor cells survival and in regulating HCC tumor
growth, we re-expressed XBP-1 in miR-214 treated HCC cells.
The results showed that restored XBP-1 expression by transfecting
pCMV-XL5-XBP-1s attenuated agomir-214 mediated XBP-1
suppression and tumor suppressor effects in vitro and in vivo (Figure
S6 and 4A–C).
Unfolded protein response downregulates miR-199a/214
expression in HCC cells
As miR-214 targets XBP-1 and XBP-1 is a key effector of UPR
and ER stress [31,32], we further investigated whether there might
be a link between miR-214 down-expression and the activation of
UPR in HCC in hepatoma cells. To validate the impact of UPR
on miR-214 expression in HCC cells, two classic UPR inducer
thapsigargin (TG) and tunicamycin (TM) was used to induce
activation of the UPR in HepG2 cells. Incubation of HepG2 cells
with TG (5 mmol/L) and TM (5 mg/mL) markedly elevated the
GRP94 and XBP1 splicing protein level, indicating UPR
activation. The real-time RT-PCR results showed that miR-214
expression was significantly down-regulated in HepG2 cells after
TG and TM treatment for 24 h (Figure 5A). As miR-199a-3p,
miR-199a-5p and miR-214 sequences were a cluster, we also
found that levels of miR-199a-3p and miR-199a-5p were
decreased compared with a vehicle group (Figure 5A). In addition,
we further tested the effect of hypoxia-induced UPR on the level of
miR-199a/214 expression. The expression levels of miR-199a and
miR-214 were also lower in HCC cells exposed to anoxia induced
by CoCl2 (100 mmol/L) (Figure 5B). Thus, miR-199a and miR-
214 expression levels are down-regulated by UPR under various
physiological and pathological conditions.
NFkB is a potential negative regulator of the miR-199a-2/
miR-214 gene
As shown in Figure S7, miR-199a2 and miR-214 were
regulated as a cluster from pri-miR-199a2 within the human
Figure 3. miR-214 regulates HCC cell proliferation and apoptosis. (A) Relative cell number of HepG2 and SMMC-7721 cells at 48 hours post-
transfection was evaluated using CCK-8 assay. (B) Cell growth rate of HepG2 and SMMC-7721 cells at 48 hours post-transfection was evaluated using
Br-dU incorporation assay. (C) After 48 hours miR-214 mimics transfection, cells were labeled with Annexin V and analyzed by flow cytometry. (D)
After 48 hours agomir-214 treatment, SMMC-7721 cells were labeled with Annexin V and analyzed by flow cytometry *P,0.05 vs untreated (HepG2
or SMMC-7721) or miR-con-treated.
doi:10.1371/journal.pone.0031518.g003
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region for transcription factor binding sites, and identified 3
potential putative NFkB binding sites in a 1.2-kb DNA fragment
upstream to the pre-miR-199a2 (Figure S8). So we tested whether
NFkB is involved in the regulation of miR-199a2/214 expression.
As shown in Figure 6A, lipopolysaccharide (LPS) (10 mg/ml), a
known inducer of NFkB activity, induced NFkB activation and
inhibited miR-199a2/214 expression in SMMC-7721 cells. In
contrast, transfection of siRNA targeting human p65 reduced
NFkB expression and increased miR-199a2/214 level in SMMC-
7721 cells (Figure 6B). These data indicated that NFkBi sa
potential negative regulator of the miR-199a-2/miR-214 cluster.
Further we found that exposure to TG induced NFkB
activation in HepG2 cells (Figure 6C), and suppressed miR-
199a2/214 expression (Figure 5A). Consistent with these results,
the potent NFkB inhibitor pyrrolidinedithiocarbamate (PDTC)
(100 mM) significantly reversed the suppressive effect of UPR on
miR-199a2/214 expression (Figure 6D), highlighting the impor-
tance of the UPR/NFkB pathway in miR-199a2/214 expression.
Further, we also explored whether NFkB is able to regulate
miR-199a/214 expression upon anoxia. Results showed that
100 mmol/L CoCl2 treatment also induced NFkB and decreased
miR-199a2/214 levels in HepG2 cells simultaneously, and
inhibition of NFkB attenuated the reduction of miR-199a2/214
levels observed after anoxic treatment (Figure 6C and E). Thus,
these data suggested that UPR mediated the negative regulation of
miR-199a2/214 though activating NFkB to participate in HCC
progression.
Discussion
MiRNAs are negative regulators of gene expression and can
function as tumor suppressors or oncogenes [33]. Some particular
miRNAs were reported to be differentially expressed in different
cancer, such as the miR-199a/214 cluster. Increased level of miR-
214 was found in ovarian cancer [28], gastric cancer [34] and
melanoma [26], inducing chemotherapy resistance or tumor
metastasis. But in cervical cancer [27,29] and breast cancer [35],
miR-214 expression was reduced, suggesting a tumor suppressor
gene-like function. The possible explanation was that individual
miRNAs targets multiple targets in different cells. Several miR-214
targets have been characterized in various tumor types (ovarian
cancer, cervical cancer and melanoma) including MEK3, JNK1
[29], PTEN [28,36], Plexin-B1 [27], Ezh2 [35,37], and TFAP2C
[26] and so on. In our study, we further identified XBP-1 as a new
target of miR-214 by binding its 39-UTR in HCC cells. Moreover,
we found that the expressions of Ezh2 and plexin-B1 were not
negatively correlated with miR-214 in miR-214-downregulated
Figure 4. Restored XBP-1 expression reduced miR-214 overexpression induced HCC tumor suppression in vitro and in vivo. (A) XBP-
1 reintroduced reversed the suppression of colony formation induced by agomir-214 treatment in SMCC-7721 cells. (B) XBP-1 reintroduced reversed
the suppression of tumor formation induced by agomir-214 treatment in nude mouse SMCC-7721 cells xenograft model. Tumor weight 4 weeks after
inoculation was measured. (C) XBP-1 reintroduced reversed the suppression of cells proliferation induced by agomir-214 treatment in SMCC-7721
cells. The results were reproducible in three independent experiments. *P,0.05 vs agomir-NC-treated; #P,0.05 vs agomir-214 or agomir-
214+vector-treated.
doi:10.1371/journal.pone.0031518.g004
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31518Figure 5. ER stress induces miR-199a/214 downregulation in HCC cells. (A) HepG2 cells treated with Thapsigargin(TG, 5 mmol/L) and
tunicamycin (TM, 5 mg/ml) for 24 h were analyzed by western blotting for GRP94 and XBP1 expression levels and analyzed by real-time RT-PCR for
miR-199a-3p/-5p and miR-214 expression. (B) HepG2 cells treated with CoCl2 (100 mM) for 24 h were analyzed by Western blotting for GRP94 and
XBP1 expression levels and analyzed by real-time RT-PCR for miR-199a-3p/-5p and miR-214 expression. Columns, mean of three independent
experiments; bars, SD; *P,0.05 vs untreated (HepG2) or DMSO-treated.
doi:10.1371/journal.pone.0031518.g005
Figure 6. The regulatory role of NFkB in miR-199a/214 Expression. (A) LPS (10 mg/ml) treatment induced NFkB p65 expression, attenuates
the miR-199a/214 expression in SMMC-7721 cells. (B) siRNA specifically targeting human NF-kB P65 subunit (100 nM) dereased NFkB p65 expresssion
and increased the expression of miR-199a/214 in SMMC-7721 cells. (C) NF-kB is activated by ER Stress and hypoxia in HepG2 cells analyzed by
Western blotting. (D, E) miR-199a/214 expression in HepG2 cells treated with ER stress inducer (5 mmol/L TG and 100 mM CoCl2) and NFkB inhibitors
PDTC (100 mM). *P,0.05 vs untreated (HepG2 or SMMC-7721) or DMSO or siRNA con-treated; #P,0.05 vs TG or CoCl2 treatment.
doi:10.1371/journal.pone.0031518.g006
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observations, we assumed that XBP-1, but not Ezh2 and plexin-
B1, is the ‘‘primary’’ target of miR214 in HCC, depending on the
different cellular context.
As we know, XBP-1, a major transcriptional regulator of the
unfolded protein response, regulates a subset of ER resident
chaperone genes in the unfolded protein response to protect
cancer cells from an inadequate environment such as hypoxia or
glucose deprivation [31], which are commonly encountered by
most solid tumors including HCC. Clonogenic survival of the
XBP-1-deficient tumor cells was significantly reduced during
severe hypoxia/anoxia in vitro and the XBP-1-knockout tumor
cells were unable to grow as tumors in vivo [30], suggesting that
XBP-1 is essential for tumor cell survival under hypoxic
conditions and solid tumor formation and growth. Previous
studies demonstrated that elevation of the splicing of XBP-1
mRNA, resulting in the activation of XBP-1product, as well as
Grp78 and ATF6, occurred in HCC tissues with increased
histological grading [38]. Similarly, we found that XBP-1 protein
level was increased in miR-214-downexpressed human HCC
tissues. Together, these studies indicated that down-regulated
miR-214 in HCC cancer induces the over-expression of XBP-1,
which in turn accelerates tumorigenesis. Interestingly, similar
result of miR-214-mediated XBP-1 repression was also attained
in Hela cells. It is consistent with recent reports that miR-214 is
down-regulated in human cervical cancer and negatively
regulates Hela cell proliferation [27,29]. It will be interesting
now to determine whether over-expression of miR-214 or
modulation of its targeting could provide a new treatment
modality for miR-214-deficient tumor, such as HCC, cervical
cancer and breast cancer.
In the other hand, our study showed that a significant down-
regulation of the miR-199a/214 cluster was observed in human
HCC tissues and HCC cell lines when compared with normal
liver, consistent with previous observations from profiling of
miRNAs expression in HCC [9,39,40,41,42]. But what is the
mechanism of the miR-199a/214 cluster down-expression in
HCC? Growing evidence has revealed that during ER stress, the
UPR represents an adaptive mechanism that supports survival and
chemoresistance of tumor cells, and has also been emerging as a
means for tumor cells to increase survival under conditions of
metabolic stress, hypoxia, and perhaps even chemotherapy [43].
Additionally, activation of MEK/ERK and mTOR have been
reported to play a critical role in controlling cell survival or cell
death signaling induced by ER stress [44,45,46]. As the UPR
transcription factor XBP-1 was identified as a target of miR-214
and recent studies have revealed the important functions of miR-
199a/b-3p in HCC carcinogenesis and progression by targeting
mTOR and c-Met or PAK4/Raf/MEK/ERK Pathway in HCC
cells [5,21], we decided to further investigate the correlation
between UPR activation and miR-199a/214 down-expression.
Result show that miR-214 and miR-199a-3p/5p was significantly
down-regulated in HepG2 cells after TG and TM treatments or
anoxia, further suggesting that UPR activated XBP-1 or mTOR
and ERK pathway to protect tumor cell survival though
suppression of the miR-199a2/214 cluster in HCC.
To start unraveling the regulatory mechanisms of miR-199a2/
214 expression under UPR conditions in greater detail, we
further found that UPR activated NFkB with concomitant
suppression of miR-199a2/214 transcription, and this suppres-
sion was reversed by NFkB inhibitor PDTC in HepG2 cells,
which suggested that NFkB is a potential negative regulator of the
miR-199a-2/miR-214 cluster. NFkB is an important transcrip-
tion factor that has emerged as an key modulator of altered gene
programs and malignant phenotype in development of cancers
[47]. Early studies indicated that many cancers, such as breast
cancer, lung cancer, and lymphoma, and HCC, constitutively
express high levels of NFkB [48,49]. In addition, hypoxia in
HCC cells and tissues induced NFkB overexpression and/or
constitutive activation [50,51]. There was a regulatory Sp1/
NFkB/HDAC/miR-29b network to control oncogene expression
in acute myeloid leukemia (AML) [52]. In our study, we showed
that NFkB and XBP-1 were predominantly expressed but miR-
214 was significantly reduced in human HCC tissues, miR-214
directly targets XBP-1, and UPR or hypoxia induced-NFkB
activation negatively controls the miR-199a/214 cluster tran-
scription in HCC cells. Therefore, a new UPR/NFkB/miR-214/
XBP-1 regulatory circuitry was suggested in HCC progression, in
which NFkB was activated by UPR and participated in the
negative regulation of miR-199a/214 to regulate HCC progres-
sion (Figure 7). This regulatory mechanism partly explained why
PDTC treatment inhibited NFkB activation, promoted HCC
cells apoptosis and suppressed tumor growth [53], while LPS
treatment induced NFkB activation and promoted tumor cell
proliferation and metastatic growth [54,55,56,57]. Certainly,
more evidences of NFkB bind site in the promoter of the miR-
199a/214 cluster are needed in future to support this hypothesis
and more investigations are needed to elucidate whether ER
stress also activate other factors (e.g.Sp1) together involved in the
downregulation of miR-199a/214 in HCC. Nevertheless, further
understanding of the molecular mechanism and network by
which the miR-199a/214 cluster functions may provide new
avenues of research that could aid early diagnosis and treatment
of this highly malignant tumor.
In summary, our findings revealed that ER stress suppresses the
expression of the miR-199a/214 cluster by activating NFkBt o
upregulate pro-survival XBP-1 expression, which suggested a
novel UPR/NFkB/miR-214/XBP-1 regulatory circuitry whose
dysfunction may contribute to tumor survival and progression of
HCC. Our study offer new insight into the tumor suppressor
activity conferred by miR-199a/214 and the potential mecha-
nisms of hepatocarcinogenesis.
Figure 7. Summary diagram describes the ER stress/NFkB/miR-
199a/214 network that regulates HCC tumorigenicity. The miR-
214/XBP-1 pathway was shown in this work, while miR-199a-3p/mTOR
and miR-199a-5p/DDR1 pathways were reported by other studies.
doi:10.1371/journal.pone.0031518.g007
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Materials and reagents
Materials were obtained from the follow suppliers: antibodies
against XBP-1, ATF6, NFkB, GAPDH, and b-actin were from
santa cruz biotechnology Inc.(Santa cruz, CA); antibodie against
GRP94 from Cell Signaling Technology (Beverly, MA); antibody
aganist p-IRE1 were from Thermo Scientific Pierce Antibodies
(Rockford, IL); cell counting kit-8 were obtained from Beyotime
Institute of Biotechnology (Nantong, China); Br-dU cell prolifer-
ation ELISA kit was obtained from Roche (Penzberg, Germany);
pCMV6-XL5-XBP-1s plasmid was purchased from Origene
(Rockville, MD); miRNA negative control (miR-con and anti-
miR-con), miR-214 mimics and anti-miR-214, agomir-214 and
agomir-NC, antagomir-214 and antagomir-NC, siRNA targeting
human NFkB/p65 were obtained from RiboBio (Guangzhou,
China); All other chemicals and reagents were purchased from
Sigma-Aldrich (Sigma-Aldrich China Inc., Shanghai, China)
unless otherwise specified.
Human tumor samples
A total of 23 snap-frozen normal and malignant liver tissues (14
men and 9 women; median age, 65.0 y; range, 50–78 y) were
collected at Tongji hospital (Wuhan, Hubei China). Human
normal liver tissues were obtained from distal normal liver tissue of
liver hemangioma patients. This study was approved by the
Review Board of Tongji Hospital and Tongji Medical College.
The subjects recruited to the study provided written informed
consent. The investigation conforms to the principles outlined in
the Declaration of Helsinki. Tissue samples were obtained and
kept frozen in liquid nitrogen and then stored at 280uC until use.
Cell culture
Human hepatoma cell line HepG2 and human cervical cancer
cell line Hela were obtained from the American Type Culture
Collection (Manassas, VA), and Human hepatoma cell line
SMMC-7721 was from the Committee on Type Culture
Collection of Chinese Academy of Sciences (Shanghai, China),
and maintained as recommended by the source. Cells were
cultured in DMEM, adjusted to contain 4 mM L-glutamine,
1.5 g/l sodium bicarbonate, 4.5 g/l glucose, 10% FBS, 100units/
ml penicillin, and 65units/ml streptomycin. All cell lines were
maintained at 37uC in a humidified incubator containing 5%
CO2.
Cell transfection and treatments
HepG2 and SMMC-7721 cells were transfected with miRNA/
siRNA negative control (miR-con and siR-con), miR-214 mimics
or siRNA targeting human NFkB/p65 (RiboBio, Guangzhou,
China) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA)
following the manufacturer’s protocol. The siRNA sequences for
human NFkB/p65 were: 59- GCC CUA UCC CUU UAC GUC
A-39 [58]. SMMC-7721 cells were treated with 100 nM agomir-
214 and agomir-NC, antagomir-214 and antagomir-NC and were
collected 24 hours after treatment for xenotransplantation into
nude mice modle and Br-dU incorporation assay. HepG2 Cells
were treated with 5 mg/ml of thapsigargin and 5 mmol/L
tunicamycin and collected 24 hours after treatment for western
blotting (WB) analyses and RNA extraction. Hypoxic conditions
were created by using 100 mM of CoCl2 for 24 hours before cell
collection.
Western blot analysis
Proteins from cell lysates (20 mg) were separated by 10% SDS-
polyacrylamide gel electrophoresis and transferred to a polyviny-
lidene difluoride membrane. After blocking in 5% nonfat milk,
protein blots were incubated with a specific antibody followed by
incubation with a peroxidase-conjugated secondary antibody in
blocking buffer. The bands were visualized with the enhanced
chemiluminescence method according to manufacturer’s instruc-
tions (Pierce Chemical Co., Rockford, IL).
RNA extraction and real-time quantitative PCR
Total RNAs (miRNA and mRNA) were extracted using
TRIzol (Invitrogen, Carlsbad, CA) according to the manufac-
ture’s protocol. Reverse transcription of total miRNA were done
starting from equal amounts of total RNA/sample (1 mg) using
EasyScript First-Strand cDNA Synthesis SuperMix (TransGen
Biotech, Beijing, China). The miR-214, miR-199a-3p and miR-
199a-5p level was quantified by real-time quantitative-PCR using
TransStartTM SYBR Green qPCR Supermix (TransGen
Biotech, Beijing, China), and with U6 small nuclear RNA as an
internal normalized reference. The expressions of pre-miR-
199a1, pre-miR-199a2, and pre-miR-214 were measured by
quantitative RT-PCR, as described previously [59,60]. The qRT-
PCR results were analyzed and expressed as relative miRNA
levels of the CT (cycle threshold) value, which was then converted
to fold change.
Vector construction and Luciferase reporter assay
The 39UTR of the human XBP-1 gene was PCR amplified
using the XBP-1 primers: 59GCG CGA GCT CTT CTC TGT
CAG TGG GGA CGT CAT39 and 39GCG CAA GCT TAG
AAG AAA TCA AAC AAG GAT GCT GC59, and cloned in
between the Hind III and Sac I sites of the pMIR-REPORT
miRNA expression reporter vector (Ambion, Inc.) using PCR-
generated fragment from genomic DNA. The 39UTR of the
human XBP-1 were mutated using an Easy Mutagenesis System
kit (TransGen Biotech,Beijing, China). For luciferase reporter
assay, HepG2 cells (1610
5) were plated in a 24-well plate and then
cotransfected with 400 ng of luciferase reporter vector and 20 ng
of pRL-TK, using Lipofectamine 2000 (Invitrogen, Carlsbad, CA)
following the manufacturer’s protocol. Luciferase activity were
detected using the Dual-Luciferase Reporter Assay System
(Promega, Madison, WI), as described previously [61]. Transfec-
tions were done in duplicates and repeated at least thrice in
independent experiments.
Cell proliferation assay
For Br-dU cell proliferation assay, 24 hours after transfection
with miR-214 mimics or treated with agomir-214, HCC cells
(HepG2 or SMMC-7721) were dispensed with trypsin and
replated in 96-well plates. Six hours later, cells in 96-well plate
was labeled with Br-dU for 18 hours. Then the levels of Br-dU
incorporation were determined using a Br-dU cell proliferation
ELISA kit (Roche, Penzberg, Germany). For CCK-8 proliferation
assay, cell proliferation was monitored using Cell Counting Kit-8
(CCK-8) (Beyotime Institute of Biotechnology, China). HepG2
and SMMC-7721 cells (3000 per well) were transfected with miR-
214 or miR-control in 96-well culture plates. 48 hours later, CCK-
8 reagent was added to each well and incubated at 37uC for 1 h.
The number of viable cells was assessed according to the
manufacturer’s protocol.
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Twenty-four hours after transfection, 200 transfected HepG2
cells were placed in a fresh cell plate and maintained in DMEM
containing 10% FBS for 2 weeks. SMMC-7721 cells were placed
in a fresh cell plate and maintained in DMEM containing 100 nM
agomir-214 or agomir-NC, 10% FBS for 2 weeks. Colonies were
fixed with methanol and stained with 0.1% crystal violet in 20%
methanol for 15 min.
Flow cytometry analysis
The apoptosis assay was performed on HepG2 cells 48 hours
after transfected with either miR-214 mimics or miR-control and
SMMC-7721 cells 48 hours after treated with agomir-214 or
agomir-NC using the Annexin V-FITC Apoptosis Detection Kit
(KeyGen Biotech, Nanjing, China) and analyzed by fluorescence -
activated cell sorting (FACS).
In vivo tumorigenesis assay
miR-214 mimics and miR-con transfected HepG2 cells (1610
6),
or agomir-214 and agomir-NC treated SMMC-7721 cells (1610
6)
transfected with pCMV-XL5-XBP-1s plasmid individually, and
were suspended in 100 mL PBS and then injected s.c. into either
side of the posterior flank of the same female BALB/c athymic
nude mouse at 5 to 6 weeks of age, as described previously
[6,16,20,62,63,64]. Tumor size was measured once every 7 days
(beginning 7 days after injection) with microcalipers. We analyzed
primary tumor growth by measuring tumor length (L) and width
(W), and calculated tumor volume according to V=(L6W
2)60.5.
At the end of the experiment (4 or 5 weeks after cell injection),
mice were sacrificed, and primary tumors were removed and
weighed. All animal studies were approved by the Animal
Research Committee of Tongji College (Permit Number: S211)
and were done according to the guidelines of the NIH.
Statistical analysis
Continuous variables are expressed as mean values 6 SD. One-
tailed student’s t test was used to compare values of test and
control samples. P,0.05 was considered significant.
Supporting Information
Figure S1 Western blot showing P-IRE1 and ATF6
protein in HepG2 cells transfected with miR-control
and miR-214 mimics, GAPDH as loading controls.
(TIF)
Figure S2 Western blot showing XBP-1protein in Hela
cells transfected with miR-control and miR-214 mimics,
b-actin as loading controls.
(TIF)
Figure S3 The NFKB and XBP-1s protein expression in
miR-214-underexpressed HCC tissues were analyzed by
western blotting.
(TIF)
Figure S4 Effect of miR-214 on colony formation of
hepatoma cell lines. HepG2 cells were plated at low density
(200 cells/well) after transfection by miR-control, miR-214
mimics. Cells were grown for 14 days, fixed, and stained by
0.1% crystal violet. *P,0.05 vs untreated (HepG2) or miR-con-
treated.
(TIF)
Figure S5 Effect of miR-214 on tumour formation in
nude mouse HepG2 xenograft model. miR-con and miR-
214 in Fig. S5 indicate the flanks injected with miR-control-
transfected and miR-214 mimics-transfected HepG2 cells, respec-
tively. Photographs illustrate representative features of tumour
growth and tumor weight 5 weeks after inoculation. Tumor
volume 5 weeks after inoculation was measured. *P,0.05 vs miR-
con-treated.
(TIF)
Figure S6 The XBP-1s protein expression in agomir-214
treated hepatoma-xenograft tissues were analyzed by
western blotting.
(TIF)
Figure S7 pre-miR-199a1, pre-miR-199a2 and pre-miR-
214 expression were detected by qRT-PCR in human
normal liver and HepG2 cells. Result show that pre-miR-
199a2 and pre-miR-214 expression were markedly decreased in
HepG2 cells, while pre-miR-199a1 expression is not altered
compared with that in human normal liver, which suggest that pri-
miR-199a2 transcription is mainly suppressed in HCC. Data are
shown as mean 6 SD (n=3). * p,0.05 vs human normal liver.
(TIF)
Figure S8 Schematic diagram showing the location of
Sp1 and NFkB binding sites on miR-199a2/214 regula-
tory region on chromosome 1.
(TIF)
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